CASTLE BIOSCIENCES, INC. Increase (Decrease) in Other Accrued Liabilities
CASTLE BIOSCIENCES, INC. (CSTL) reported Increase (Decrease) in Other Accrued Liabilities of $5.31 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. increase (decrease) in other accrued liabilities for the quarter ending 2026-06-30 was $2.56M.
- CASTLE BIOSCIENCES, INC. increase (decrease) in other accrued liabilities for the quarter ending 2026-03-31 was $2.75M, a 141.45% increase year-over-year.
- CASTLE BIOSCIENCES, INC. increase (decrease) in other accrued liabilities for the quarter ending 2025-12-31 was -$1.03M.
- CASTLE BIOSCIENCES, INC. increase (decrease) in other accrued liabilities for the quarter ending 2025-09-30 was $1.43M, a 46.01% increase year-over-year.
- CASTLE BIOSCIENCES, INC. increase (decrease) in other accrued liabilities for fiscal 2025 was $870.00K, a 171.88% increase from fiscal 2024.
- CASTLE BIOSCIENCES, INC. increase (decrease) in other accrued liabilities for fiscal 2024 was $320.00K, a 85.04% decline from fiscal 2023.
- CASTLE BIOSCIENCES, INC. increase (decrease) in other accrued liabilities for fiscal 2023 was $2.14M.
- CASTLE BIOSCIENCES, INC. increase (decrease) in other accrued liabilities for fiscal 2022 was -$963.00K, a 142.13% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 6 month as first filed | Increase (Decrease) in Other Accrued Liabilities 9 month | Increase (Decrease) in Other Accrued Liabilities 9 month as first filed | Increase (Decrease) in Other Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $5.31M 10-Q · filed 2026-07-30 | $4.28M derived: sum of 3 quarters · filed 2026-07-30 | $5.71M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2026-03-31 | $2.75M 10-Q · filed 2026-05-06 | $1.72M derived: sum of 2 quarters · filed 2026-05-06 | $3.15M derived: sum of 3 quarters · filed 2026-05-06 | $2.48M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-12-31 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $396.00K derived: sum of 2 quarters · filed 2026-02-26 | -$271.00K derived: sum of 3 quarters · filed 2026-07-30 | $870.00K 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $761.00K derived: sum of 2 quarters · filed 2026-07-30 | $1.90M 10-Q · filed 2025-11-03 | $1.18M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-06-30 | -$667.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $474.00K 10-Q · filed 2026-07-30 | -$252.00K derived: sum of 3 quarters · filed 2026-07-30 | $726.00K derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-03-31 | $1.14M 10-Q · filed 2026-05-06 | $415.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.39M derived: sum of 3 quarters · filed 2026-05-06 | $1.39M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | -$726.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $252.00K derived: sum of 2 quarters · filed 2026-02-26 | $247.00K derived: sum of 3 quarters · filed 2026-02-26 | $320.00K 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $978.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $973.00K derived: sum of 2 quarters · filed 2025-11-03 | $1.05M 10-Q · filed 2025-11-03 | $1.81M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $68.00K 10-Q · filed 2025-08-04 | $831.00K derived: sum of 3 quarters · filed 2026-02-26 | $160.00K derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $73.00K 10-Q · filed 2025-05-05 | $836.00K derived: sum of 2 quarters · filed 2026-02-26 | $165.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.20M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $763.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $92.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.13M derived: sum of 3 quarters · filed 2026-02-26 | $2.14M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | -$671.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $362.00K derived: sum of 2 quarters · filed 2024-11-04 | $1.38M 10-Q · filed 2024-11-04 | $1.27M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $2.05M 10-Q · filed 2024-08-05 | $1.94M derived: sum of 3 quarters · filed 2025-02-27 | -$27.00K derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $1.01M 10-Q · filed 2024-05-02 | $904.00K derived: sum of 2 quarters · filed 2025-02-27 | -$1.06M derived: sum of 3 quarters · filed 2025-02-27 | $22.00K derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | -$110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$2.07M derived: sum of 2 quarters · filed 2025-02-27 | -$992.00K derived: sum of 3 quarters · filed 2025-02-27 | -$963.00K 10-K · filed 2025-02-27 | ||
| 2022-09-30 | -$1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$882.00K derived: sum of 2 quarters · filed 2023-11-02 | -$853.00K 10-Q · filed 2023-11-02 | $814.00K derived: sum of 4 quarters · filed 2023-11-02 | ||
| 2022-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $1.11M 10-Q · filed 2023-08-02 | $2.78M derived: sum of 3 quarters · filed 2023-08-02 | $3.70M derived: sum of 4 quarters · filed 2023-08-02 | ||
| 2022-03-31 | $29.00K 10-Q · filed 2023-05-03 | $1.70M derived: sum of 2 quarters · filed 2023-05-03 | $2.62M derived: sum of 3 quarters · filed 2023-05-03 | $2.65M derived: sum of 4 quarters · filed 2023-05-03 | ||
| 2021-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $2.59M derived: sum of 2 quarters · filed 2023-02-28 | $2.62M derived: sum of 3 quarters · filed 2023-02-28 | $2.29M 10-K · filed 2023-02-28 | ||
| 2021-09-30 | $925.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $949.00K derived: sum of 2 quarters · filed 2022-11-02 | $619.00K 10-Q · filed 2022-11-02 | -$529.00K derived: sum of 4 quarters · filed 2022-11-02 | ||
| 2021-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$306.00K 10-Q · filed 2022-08-08 | -$1.45M derived: sum of 3 quarters · filed 2022-08-08 | -$8.00K derived: sum of 4 quarters · filed 2022-08-08 | ||
| 2021-03-31 | -$330.00K 10-Q · filed 2022-05-09 | -$1.48M derived: sum of 2 quarters · filed 2022-05-09 | -$32.00K derived: sum of 3 quarters · filed 2022-05-09 | $327.00K derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2020-12-31 | -$1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $298.00K derived: sum of 2 quarters · filed 2022-02-28 | $657.00K derived: sum of 3 quarters · filed 2022-02-28 | $561.00K 10-K · filed 2022-02-28 | ||
| 2020-09-30 | $1.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $1.80M derived: sum of 2 quarters · filed 2021-11-08 | $1.71M 10-Q · filed 2021-11-08 | $2.33M derived: sum of 4 quarters · filed 2021-11-08 | ||
| 2020-06-30 | $359.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $263.00K 10-Q · filed 2021-08-09 | $879.00K derived: sum of 3 quarters · filed 2021-08-09 | $240.00K derived: sum of 4 quarters · filed 2021-08-09 | ||
| 2020-03-31 | -$96.00K 10-Q · filed 2021-05-10 | $520.00K derived: sum of 2 quarters · filed 2021-05-10 | -$119.00K derived: sum of 3 quarters · filed 2021-05-10 | $462.00K derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $616.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$23.00K derived: sum of 2 quarters · filed 2021-03-11 | $558.00K derived: sum of 3 quarters · filed 2021-03-11 | $879.00K 10-K · filed 2021-03-11 | ||
| 2019-09-30 | -$639.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$58.00K derived: sum of 2 quarters · filed 2020-11-09 | $263.00K 10-Q · filed 2020-11-09 | $261.74K 10-Q · filed 2019-11-12 | $380.20K derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $581.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $902.00K 10-Q · filed 2020-08-10 | $901.62K 10-Q · filed 2019-09-03 | $1.02M derived: sum of 3 quarters · filed 2020-08-10 | $1.07M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | $321.00K 10-Q · filed 2020-05-11 | $438.20K derived: sum of 2 quarters · filed 2020-05-11 | $488.69K derived: sum of 3 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $117.20K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $167.69K derived: sum of 2 quarters · filed 2020-03-10 | $201.00K 10-K · filed 2020-03-10 | |||
| 2018-09-30 | $50.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $83.80K 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | $33.30K 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |